BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 464443)

  • 1. Pulmonary effects of carmustine (bischloroethylnitrosourea, BCNU).
    Sweet DL
    Ann Intern Med; 1979 Jul; 91(1):132-3. PubMed ID: 464443
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary effects of carmustine (bischloroethylnitrosourea, BCNU).
    Stillerman R
    Ann Intern Med; 1979 Jul; 91(1):132. PubMed ID: 464442
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary effects of carmustine (bischloroethylnitrosourea, BCNU).
    Weiss RB; Muggia FM
    Ann Intern Med; 1979 Jul; 91(1):131-2. PubMed ID: 464441
    [No Abstract]   [Full Text] [Related]  

  • 4. Pulmonary effects of carmustine (bischloroethylnitrosourea, BCNU).
    Kaplan RL
    Ann Intern Med; 1979 Jul; 91(1):131. PubMed ID: 464440
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fatal pulmonary fibrosis induced by cytotoxic therapy].
    Somló P; Révész T
    Orv Hetil; 1984 May; 125(19):1143-5. PubMed ID: 6718003
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recurrent bilateral pneumothorax in progressive lung fibrosis following combination therapy with BCNU].
    Vetter N; Berger E; Otupal I; Jürgenssen OA
    Prax Klin Pneumol; 1985 Mar; 39(3):102-5. PubMed ID: 3991454
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulmonary effects of cytotoxic agents other than bleomycin.
    Twohig KJ; Matthay RA
    Clin Chest Med; 1990 Mar; 11(1):31-54. PubMed ID: 1691069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU).
    Durant JR; Norgard MJ; Murad TM; Bartolucci AA; Langford KH
    Ann Intern Med; 1979 Feb; 90(2):191-4. PubMed ID: 443651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal pulmonary fibrosis associated with BCNU: the relative role of platelet-derived growth factor-B, insulin-like growth factor I, transforming growth factor-beta1 and cyclooxygenase-2.
    Shen YC; Chiu CF; Chow KC; Chen CL; Liaw YC; Yeh SP
    Bone Marrow Transplant; 2004 Oct; 34(7):609-14. PubMed ID: 15286697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary toxicity in long-term administration of BCNU.
    Holoye PY; Jenkins DE; Greenberg SD
    Cancer Treat Rep; 1976 Nov; 60(11):1691-4. PubMed ID: 1021241
    [No Abstract]   [Full Text] [Related]  

  • 11. Late BCNU lung: a light and ultrastructural study on the delayed effect of BCNU on the lung parenchyma.
    Hasleton PS; O'Driscoll BR; Lynch P; Webster A; Kalra SJ; Gattamaneini HR; Woodcock AA; Poulter LW
    J Pathol; 1991 May; 164(1):31-6. PubMed ID: 2056387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early pulmonary toxicity after administration of high-dose BCNU.
    Litam JP; Dail DH; Spitzer G; Vellekoop L; Verma DS; Zander AR; Dicke KA
    Cancer Treat Rep; 1981; 65(1-2):39-44. PubMed ID: 6261949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic lung fibrosis following carmustine (BCNU) chemotherapy: radiological features.
    Taylor PM; O'Driscoll BR; Gattamaneni HR; Woodcock AA
    Clin Radiol; 1991 Nov; 44(5):299-301. PubMed ID: 1760904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progressive pulmonary fibrosis during combination chemotherapy with BCNU (author's transl)].
    Schreml W; Bargon G; Anger B; Kubanek B; Heimpel H
    Blut; 1978 Jun; 36(6):353-6. PubMed ID: 656638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary fibrosis following low-dose 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) therapy.
    Melato M; Tuveri G
    Cancer; 1980 Mar; 45(6):1311-4. PubMed ID: 7357522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary fibrosis after prolonged therapy with 1,3-bis (2-chloroethyl)-1-nitrosourea.
    Crittenden D; Tranum BL; Haut A
    Chest; 1977 Sep; 72(3):372-3. PubMed ID: 891293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma for delayed pulmonary toxicity syndrome resistant to steroids.
    Suratt BT; Lynch DA; Cool CD; Jones RB; Brown KK
    Bone Marrow Transplant; 2003 May; 31(10):939-41. PubMed ID: 12748674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed pulmonary fibrosis after nitrosourea therapy.
    Limper AH; McDonald JA
    N Engl J Med; 1990 Aug; 323(6):407-9. PubMed ID: 2370891
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulmonary toxicity from carmustine (BCNU): a case report.
    Weiss RB; Shah S; Shane SR
    Med Pediatr Oncol; 1979; 6(3):255-9. PubMed ID: 470840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upper lobe pulmonary fibrosis associated with high-dose chemotherapy containing BCNU for bone marrow transplantation.
    Parish JM; Muhm JR; Leslie KO
    Mayo Clin Proc; 2003 May; 78(5):630-4. PubMed ID: 12744552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.